These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Sprironolactone-induced gynecomastia]. Keil-Kuri E; Marshall M Z Allgemeinmed; 1972 Jul; 48(19):896-7. PubMed ID: 4640137 [No Abstract] [Full Text] [Related]
6. Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure. Teive HA; Munhoz RP; Werneck LC Mov Disord; 2007 Aug; 22(11):1678-9. PubMed ID: 17534964 [No Abstract] [Full Text] [Related]
7. [Iatrogenic gynecomastia in aldosterone-antagonist therapy]. Quietzsch D Z Gesamte Inn Med; 1981 Feb; 36(3):87-9. PubMed ID: 7222857 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced gynecomastia. Thompson DF; Carter JR Pharmacotherapy; 1993; 13(1):37-45. PubMed ID: 8094898 [TBL] [Abstract][Full Text] [Related]
18. Male breast uptake in rubidium-82 PET due to spironolactone-induced gynecomastia. Kiehl EL; Shivapour DM; Goenka AH; Jaber WA J Nucl Cardiol; 2015 Oct; 22(5):1148-50. PubMed ID: 25537612 [No Abstract] [Full Text] [Related]
19. Gynaecomastia after spironolactone and potassium canrenoate. Bellati G; Idéo G Lancet; 1986 Mar; 1(8481):626. PubMed ID: 2869341 [No Abstract] [Full Text] [Related]